A phase I/II trial of gemcitabine and S-1 therapy in patients with resected pancreatic cancer: Japanese Study Group of Adjuvant Therapy for Pancreatic Cancer (JSAP-03). The impact of diabetes mellitus ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback